Camp4 Therapeutics

(NASDAQ) CAMP

Current Price$4.13

Market Cap$203.55M

Since IPO (2024)-61%

5 YearN/A

1 Year+182%

1 Month-0%

Camp4 Therapeutics Financials at a Glance

Market Cap

$203.55M

Revenue (TTM)

$3.93M

Net Income (TTM)

-$86.30M

EPS (TTM)

-$2.27

P/E Ratio

-1.73

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$4.13

Volume

3,406,293.704

Open

$4.03

Price

$4.13

Volume

3,406,293.704

Open

$4.03

Previous Close

$4.20

Daily Range

$3.82 - $4.31

52-Week Range

$1.32 - $7.75

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$4.13

Volume

3,406,293.704

Open

$4.03

Previous Close

$4.20

Daily Range

$3.82 - $4.31

52-Week Range

$1.32 - $7.75

Estimated Earnings Date

Aug 13, 2026

CAMP News

Camp4 Reports Q2 Revenue Beats Estimates

Motley Fool Markets TeamAug 14, 2025

CAMP: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Camp4 Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Josh Mandel-Brehm, MBA

Website

www.camp4tx.com

Headquarters

Cambridge, MA 02139, US

CAMP Financials

Key Financial Metrics (TTM)

Gross Margin

76.21%

Operating Margin

-1322.62%

Net Income Margin

-2193.72%

Return on Equity

-194.74%

Return on Capital

-104.80%

Return on Assets

-81.84%

Earnings Yield

-57.80%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$203.55M

Shares Outstanding

51.93M

Volume

3.41M

Avg. Volume

99.38K

Financials (TTM)

Gross Profit

$3.00M

Operating Income

-$52.03M

EBITDA

-$52.24M

Operating Cash Flow

-$26.25M

Capital Expenditure

$0.00

Free Cash Flow

-$26.25M

Cash & ST Invst.

$99.21M

Total Debt

$2.12M

Camp4 Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.29M

+50.8%

Gross Profit

$774.00K

-9.8%

Gross Margin

59.81%

N/A

Market Cap

$203.55M

N/A

Market Cap/Employee

$3.70M

N/A

Employees

N/A

Net Income

-$18.33M

-47.4%

EBITDA

-$12.55M

+1.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$99.21M

+101.1%

Total Debt

$2.12M

-73.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$1.74M

-63.5%

Short Term Debt

$384.00K

-87.7%

Return on Assets

-81.84%

N/A

Return on Invested Capital

-58.57%

N/A

Free Cash Flow

-$10.98M

+24.6%

Operating Cash Flow

-$10.98M

+23.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

UNCYUnicycive Therapeutics, Inc.

UNCYUnicycive Therapeutics, Inc.$7.13-13.15%

ALXOALX Oncology Holdings Inc.

ALXOALX Oncology Holdings Inc.$2.04+13.97%

RPTXRepare Therapeutics Inc.

RPTXRepare Therapeutics Inc.$2.65+0.00%

BMEABiomea Fusion, Inc.

BMEABiomea Fusion, Inc.$1.32+7.32%

HYFTMindWalk Holdings Corp.

HYFTMindWalk Holdings Corp.$1.58+3.95%

PMVPPMV Pharmaceuticals, Inc.

PMVPPMV Pharmaceuticals, Inc.$1.19+3.48%

ACRVAcrivon Therapeutics, Inc. Common Stock

ACRVAcrivon Therapeutics, Inc. Common Stock$1.68+6.33%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

ONDSOndas

ONDSOndas$7.83+0.02%

HLHecla Mining

HLHecla Mining$15.54+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

NWLNewell Brands

NWLNewell Brands$5.82-0.01%

WENWendy's

WENWendy's$7.80+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.83-0.04%

Questions About CAMP

What is the current price of Camp4 Therapeutics?

Camp4 Therapeutics is trading at $4.20 per share.

What is the 52-week range for Camp4 Therapeutics?

Over the past 52 weeks, Camp4 Therapeutics has traded between $1.32 and $7.75.

How much debt does Camp4 Therapeutics have?

As of the most recent reporting period, Camp4 Therapeutics reported total debt of $2.12M.

How much cash does Camp4 Therapeutics have on hand?

Camp4 Therapeutics reported $99.94M in cash and cash equivalents in its most recent financial results.

What is Camp4 Therapeutics’s dividend yield?

Camp4 Therapeutics does not currently have a dividend yield.

Camp4 Therapeutics

Camp4 Therapeutics Financials at a Glance

CAMP News

Camp4 Reports Q2 Revenue Beats Estimates

CAMP: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Camp4 Therapeutics

CAMP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Camp4 Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CAMP

What is the current price of Camp4 Therapeutics?

What is the 52-week range for Camp4 Therapeutics?

How much debt does Camp4 Therapeutics have?

How much cash does Camp4 Therapeutics have on hand?

What is Camp4 Therapeutics’s dividend yield?

Premium Investing Services